More than 31 million Americans are living with eczema/ atopic dermatitis (AD), a chronic inflammatory skin condition that extends far beyond visible symptoms to disrupt sleep, mental health, and daily ...

J&J paid Numab Therapeutics $1.25 billion upfront for the asset in 2024 based on the belief that its dual mechanism of action ...

Johnson & Johnson has discontinued a phase 2 trial of one of its pipeline candidates for atopic dermatitis (AD), after it ...

Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...

Atopic dermatitis is the most common type of eczema, and it's primarily diagnosed by a visual examination and collecting your health history. There are no laboratory tests that can confirm an atopic ...

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of the randomized, blinded, placebo-controlled ...

HealthDay News — Iron deficiency without anemia is a common feature of moderate-to-severe atopic dermatitis (AD), according to a study published online Nov. 27 in Nutrients.

If you have atopic dermatitis, a skin condition commonly known as eczema, prescription creams or other topical medicines and moisturizers are usually enough to manage it. However, if your eczema is ...

Children conceived through assisted reproductive technology (ART) were modestly more likely to develop asthma, allergic ...

The number of systemic anti-inflammatory therapies for dermatologic diseases in children is expected to grow in 2026.